Cannabinoid Encyclopedia

How cannabinoids work

What is TRPA1?

A simple explanation of TRPA1, why cannabinoid researchers study it, and what its biology can and cannot tell us.

Updated July 2026 18 research sources Mostly early-stage research

The short answer

Where TRPA1 fits into cannabinoid biology

TRPA1 is a biological target studied to understand how cannabinoids affect cells and signaling. Research on CBD, THC, Cannabinoids, and Endocannabinoids helps explain possible mechanisms. This page brings together 1 human-study source, 8 research reviews, and 8 lab, animal, or mechanism sources. Most of the current evidence is preclinical or focused on biological mechanisms. A mechanism alone does not prove that a cannabinoid will produce a health benefit in people. 1

Choose your next step

Want the quick path or the full picture?

Use this guide the way you need to. Start with the practical question, then open the study detail only when it helps answer something about TRPA1.

What researchers studiedSee the main areas and the evidence behind each one. Safety and limitsKeep product, dose, medications, and context in view. Open the sourcesGo directly to the studies and references used here.

Key takeaways

What to know first

  1. 1

    Research on TRPA1 covers CBD, THC, and Cannabinoids; those areas should not be combined into one claim. 1

  2. 2

    Most of the current evidence is preclinical or focused on biological mechanisms. 2

  3. 3

    Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 3

Research areas

What researchers studied about TRPA1

These are the main questions represented in the current literature. Each link opens a source used to build the overview.

Mostly mechanism-focused

CBD

Studies examine how CBD connects with TRPA1 or closely related target biology. These findings help explain signaling and pharmacology, not a guaranteed health effect. 2

Mostly mechanism-focused

THC

Studies examine how THC connects with TRPA1 or closely related target biology. These findings help explain signaling and pharmacology, not a guaranteed health effect. 3

Mostly mechanism-focused

Cannabinoids

Studies examine how Cannabinoids connects with TRPA1 or closely related target biology. These findings help explain signaling and pharmacology, not a guaranteed health effect. 4

Mostly mechanism-focused

Endocannabinoids

Studies examine how Endocannabinoids connects with TRPA1 or closely related target biology. These findings help explain signaling and pharmacology, not a guaranteed health effect. 5

How strong is the research?

Not every study answers the same question

This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.

1 source

Human studies

Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.

8 sources

Reviews and evidence summaries

Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.

8 sources

Lab, animal, and mechanism research

Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.

Another 1 of 18 research source could not be placed cleanly into those three groups from the recorded study details.

What these studies actually looked at

The research on TRPA1 is not one kind of study. This source set includes 7 narrative or expert reviews, 5 animal studies, 2 cell or laboratory studies, and 1 systematic review or meta-analysis. 3

The recorded populations or models include animal models (5 sources), cells or tissue models (4 sources), and people or patients (2 sources). A result from one group or model should not be assumed to apply to another. 4

The most common recorded outcome focus is tRPA1 channel activity, desensitization, binding, signaling, or pharmacology (18 sources). Closely related outcome names can still describe different measurements. 5

The TRPA1 source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 6

Examples from the literature

What did the studies actually look at?

Each example names the research question and the study details recorded for that source.

narrative or expert review

TRPA1.

On this page, this source examines Cannabinoids activity involving TRPA1. 1

Study type
narrative or expert review
Population or model
cells or tissue models
Outcome focus
tRPA1 channel activity, desensitization, binding, signaling, or pharmacology
Evidence stage
evidence still limited

narrative or expert review

Pharmacological effects of cannabidiol by transient receptor potential channels.

On this page, this source examines CBD activity involving TRPA1. 2

Study type
narrative or expert review
Outcome focus
tRPA1 channel activity, desensitization, binding, signaling, or pharmacology
Evidence stage
evidence still limited

narrative or expert review

Cannabinoid Ligands Targeting TRP Channels.

On this page, this source examines THC activity involving TRPA1. 3

Study type
narrative or expert review
Outcome focus
tRPA1 channel activity, desensitization, binding, signaling, or pharmacology
Evidence stage
evidence still limited

narrative or expert review

Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia.

On this page, this source examines Cannabinoids activity involving TRPA1. 4

Study type
narrative or expert review
Outcome focus
tRPA1 channel activity, desensitization, binding, signaling, or pharmacology
Evidence stage
evidence still limited

animal study

Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist.

On this page, this source examines Endocannabinoids activity involving TRPA1. 5

Study type
animal study
Population or model
animal models
Outcome focus
tRPA1 channel activity, desensitization, binding, signaling, or pharmacology
Evidence stage
mechanism-focused research

Safety and limits

What should readers keep in mind?

Research on TRPA1 should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2

Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.

Drug interactions Pregnancy and children Driving and impairment All safety topics

Common questions

Questions people ask

What does TRPA1 do?

TRPA1 is studied as part of cannabinoid-related biology and signaling. The exact role depends on the tissue, compound, and experimental setting. 7

Does a biological mechanism prove a health effect?

No. A mechanism can explain why an idea is plausible, but human studies are needed to test whether it changes a health outcome. 8

What research is linked to TRPA1?

The main areas on this page include CBD, THC, Cannabinoids, and Endocannabinoids. The source links show the study type behind each area. 9

Sources

Read the research

The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.

  1. 1
    TRPA1. narrative or expert review; evidence still limited PubMed 24756722 DOI 10.1007/978-3-642-54215-2_23
  2. 2
    Pharmacological effects of cannabidiol by transient receptor potential channels. narrative or expert review; evidence still limited PubMed 35483477 DOI 10.1016/j.lfs.2022.120582
  3. 3
    Cannabinoid Ligands Targeting TRP Channels. narrative or expert review; evidence still limited PubMed 30697147 DOI 10.3389/fnmol.2018.00487
  4. 4
    Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia. narrative or expert review; evidence still limited PubMed 19070372 DOI 10.1016/j.tips.2008.10.008
  5. 5
    Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist. animal study; mechanism-focused research PubMed 25065940 DOI 10.1016/j.bmc.2014.07.006
  6. 6
    Systematic Review on Transdermal/Topical Cannabidiol Trials: A Reconsidered Way Forward. systematic review or meta-analysis; evidence still limited PubMed 35605018 DOI 10.1089/can.2021.0154
  7. 7
    Cannabinoids in the landscape of cancer. narrative or expert review; evidence still limited PubMed 34259916 DOI 10.1007/s00432-021-03710-7
  8. 8
    G-protein coupled receptors regulating cough. narrative or expert review; evidence still limited PubMed 21727026 DOI 10.1016/j.coph.2011.06.005
  9. 9
    Molecular Targets of the Phytocannabinoids: A Complex Picture. narrative or expert review; evidence still limited PubMed 28120232 DOI 10.1007/978-3-319-45541-9_4
  10. 10
    Affinin, Isolated from Heliopsis longipes, Induces an Antihypertensive Effect That Involves CB1 Cannabinoid Receptors and TRPA1 and TRPV1 Channel Activation. animal study; mechanism-focused research PubMed 38219731 DOI 10.1055/a-2244-8855
  11. 11
    Cannabidiol activation of vagal afferent neurons requires TRPA1. animal study; mechanism-focused research PubMed 32965166 DOI 10.1152/jn.00128.2020
  12. 12
    Cannabinoid receptor antagonists AM251 and AM630 activate TRPA1 in sensory neurons. animal study; mechanism-focused research PubMed 21645531 DOI 10.1016/j.neuropharm.2011.05.024
See all 18 research sources

This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.

  1. Cannabinoid Ligands Targeting TRP Channels. narrative or expert review; evidence still limited / 1 linked research note PubMed 30697147
  2. Pharmacological effects of cannabidiol by transient receptor potential channels. narrative or expert review; evidence still limited / 1 linked research note PubMed 35483477
  3. Cannabinoids in the landscape of cancer. narrative or expert review; evidence still limited / 1 linked research note PubMed 34259916
  4. Iodine-Promoted Aromatization of p-Menthane-Type Phytocannabinoids. evidence still limited / 1 linked research note PubMed 29240420
  5. Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia. narrative or expert review; evidence still limited / 1 linked research note PubMed 19070372
  6. Modification of TRPV4 activity by acetaminophen. animal study; mechanism-focused research / 1 linked research note PubMed 32051870
  7. TRPA1. narrative or expert review; evidence still limited / 1 linked research note PubMed 24756722
  8. Identification of the TRPA1 cannabinoid-binding site. mechanism-focused research / 1 linked research note PubMed 39368566
  9. Affinin, Isolated from Heliopsis longipes, Induces an Antihypertensive Effect That Involves CB1 Cannabinoid Receptors and TRPA1 and TRPV1 Channel Activation. animal study; mechanism-focused research / 1 linked research note PubMed 38219731
  10. Molecular Targets of the Phytocannabinoids: A Complex Picture. narrative or expert review; evidence still limited / 1 linked research note PubMed 28120232
  11. G-protein coupled receptors regulating cough. narrative or expert review; evidence still limited / 1 linked research note PubMed 21727026
  12. Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist. animal study; mechanism-focused research / 1 linked research note PubMed 25065940
  13. Cannabinoid receptor antagonists AM251 and AM630 activate TRPA1 in sensory neurons. animal study; mechanism-focused research / 1 linked research note PubMed 21645531
  14. Cannabidiol activation of vagal afferent neurons requires TRPA1. animal study; mechanism-focused research / 1 linked research note PubMed 32965166
  15. Myrcene and terpene regulation of TRPV1. cell or laboratory study; evidence still limited / 1 linked research note PubMed 31446830
  16. Systematic Review on Transdermal/Topical Cannabidiol Trials: A Reconsidered Way Forward. systematic review or meta-analysis; evidence still limited / 1 linked research note PubMed 35605018
  17. Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 32873774
  18. Phytochemical Characterization and TRPA1/TRPM8 Modulation Profile of the Cannabigerol-Rich Cannabis sativa L. Chemotype IV. mechanism-focused research / 1 linked research note PubMed 38408345